Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy

被引：21

作者：

Wolter, Daniel J. ^{[1
]}

Acquazzino, Dee ^{[2
]}

Goering, Richard V. ^{[1
]}

Sammut, Paul ^{[2
]}

Khalaf, Noha ^{[1
]}

Hanson, Nancy D. ^{[1
]}

机构：

[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Antiinfect & Biotechnol, Omaha, NE 68178 USA

[2] Univ Nebraska Med Ctr, Dept Pediat, Div Pulm Cyst Fibrosis, Omaha, NE USA

来源：

CLINICAL INFECTIOUS DISEASES | 2008年 / 46卷 / 12期

关键词：

D O I：

10.1086/588484

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The emergence of carbapenem-resistant Pseudomonas aeruginosa in the lung of a patient with cystic fibrosis was evaluated. A single strain of P. aeruginosa persisted during a 3-year study despite antipseudomonal treatment. A stepwise decrease in carbapenem susceptibility leading to resistance was observed in the absence of carbapenem treatment. These data suggest that chronic exposure to unrelated drug classes may be an important determinant for the emergence of carbapenem resistance in P. aeruginosa.

引用

页码：E137 / E141

页数：5

共 50 条

[31] Carbapenem-Resistant Pseudomonas aeruginosa in Chronic Lung Infection: Current Resistance Profile and Hypermutability in Patients with Cystic Fibrosis
Almeida, Mila M.
Freitas, Meyvianne T.
Folescu, Tania W.
Firmida, Monica C.
Carvalho-Assef, Ana Paula D'A.
Marques, Elizabeth A.
Leao, Robson S.
CURRENT MICROBIOLOGY, 2021, 78 (02) : 696 - 704
[32] Carbapenem Nonsusceptibility with Modified OprD in Clinical Isolates of Pseudomonas aeruginosa from India
Choudhury, Debarati
Das Talukdar, Anupam
Choudhury, Manabendra Dutta
Maurya, Anand Prakash
Chanda, Debadatta Dhar
Chakravorty, Atanu
Bhattacharjee, Amitabha
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 35 (01) : 137 - 139
[33] Carbapenem-hydrolysing β-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal
Cardoso, O
Sousa, JC
Leitao, R
Peixe, L
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) : 135 - 135
[34] Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodriguez-Martinez, Jose-Manuel
Poirel, Laurent
Nordmann, Patrice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4783 - 4788
[35] INVESTIGATION OF KPC GENES BY PCR AND EVALUATION OF CARBAPENEM INACTIVATION METHOD IN CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA ISOLATES
Biyik, Ilknur
Cayci, Yeliz Tanriverdi
Birinci, Asuman
ACTA MEDICA MEDITERRANEA, 2020, 36 (04): : 2331 - 2335
[36] Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals
Mathlouthi, Najla
Areig, Zaynab
Al Bayssari, Charbel
Bakour, Sofiane
El Salabi, Allaaeddin Ali
Ben Gwierif, Salha
Zorgani, Abdulaziz A.
Ben Slama, Karim
Chouchani, Chedly
Rolain, Jean-Marc
MICROBIAL DRUG RESISTANCE, 2015, 21 (03) : 335 - 341
[37] Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
Jalal, S
Ciofu, O
Hoiby, N
Gotoh, N
Wretlind, B
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 710 - 712
[38] Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
Islam, S.
Oh, H.
Jalal, S.
Karpati, F.
Ciofu, O.
Hoiby, N.
Wretlind, B.
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (01) : 60 - 66
[39] Emergence of Carbapenem Resistance Due to the Novel Insertion Sequence ISPa8 in Pseudomonas aeruginosa
Fowler, Randal C.
Hanson, Nancy D.
PLOS ONE, 2014, 9 (03):
[40] Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates
Quale, J
Bratu, S
Gupta, J
Landman, D
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1633 - 1641

← 1 2 3 4 5 →